Target Name: PAR Receptor
NCBI ID: P24743
Review Report on PAR Receptor Target / Biomarker Content of Review Report on PAR Receptor Target / Biomarker
PAR Receptor
Other Name(s): None

PAR Receptor: A Potential Drug Target and Biomarker

Parathyroid hormone (PTH) is a hormone produced by the parathyroid gland that plays a crucial role in regulating calcium levels in the body. It is essential for maintaining the proper levels of calcium in the blood, which is essential for various physiological functions such as muscle contractions, nerve function, and blood clotting. When the levels of calcium in the blood become too low or too high, PTH is released to regulate them.

Parathyroid hormone has been identified as a potential drug target due to its various physiological functions and its involvement in various diseases. One of the parathyroid gland's main functions is to regulate the levels of calcium in the blood. It is known that in humans, the parathyroid gland produces around 50% of all PTH in the body. This hormone is responsible for maintaining the proper levels of calcium in the blood, which is essential for various physiological functions.

The PAR receptor is a protein that is found on the surface of many tissues in the body. It is known to play a crucial role in the regulation of calcium levels in the body. The PAR receptor is composed of two subtypes, PAR-1 and PAR-2. PAR-1 is the most abundant subtype, and it is found in various tissues throughout the body, including the brain, heart, skeletal muscles, and uterus. PAR-2 is the least abundant subtype, and it is found in the uterus and testes.

The PAR receptor is involved in the regulation of various physiological functions, including bone growth and development, nerve function, and blood clotting. It is also involved in the regulation of the levels of calcium in the blood. The PAR receptor plays a crucial role in the regulation of calcium levels by controlling the production and release of PTH.

One of the potential benefits of targeting the PAR receptor is its potential as a drug target. By blocking the activity of the PAR receptor, it is possible to reduce the levels of PTH in the body, which can be useful in the treatment of various diseases. For example, in cases of hyperparathyroidism, which is the condition in which the parathyroid gland produces too much PTH, blocking the activity of the PAR receptor can be an effective way to treat the condition.

Another potential benefit of targeting the PAR receptor is its potential as a biomarker. The PAR receptor is involved in the regulation of various physiological functions, including bone growth and development, nerve function, and blood clotting. Therefore, measuring the levels of the PAR receptor in the body can be an effective way to monitor the health of various tissues and organs. This can be useful in the diagnosis and treatment of various diseases.

The PAR receptor is also involved in the regulation of the levels of calcium in the blood. It is known that in humans, the parathyroid gland produces around 50% of all PTH in the body. This hormone is responsible for maintaining the proper levels of calcium in the blood, which is essential for various physiological functions. Therefore, measuring the levels of the PAR receptor in the body can be an effective way to monitor the health of the parathyroid gland.

In conclusion, the PAR receptor is a protein that is found on the surface of many tissues in the body. It is involved in the regulation of various physiological functions, including bone growth and development, nerve function, and blood clotting. It is also involved in the regulation of the levels of calcium in the blood. The PAR receptor plays a crucial role in the regulation of calcium levels by controlling the production and release of PTH.

Targeting the PAR receptor has the potential to be an effective way to treat various diseases, including hyperparathyroidism. By blocking the activity of the PAR receptor, it is possible to reduce the levels of PTH in the body, which can be useful in the treatment of this condition. Additionally, measuring the levels of the PAR receptor in the body can be an effective way to monitor the health of various tissues and organs, which can be

Protein Name: PAR Receptor (nonspecified Subtype)

The "PAR Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PAR Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PAR-3-PAR-6B-PRKCI complex | Parathyroid Hormone Receptors (PTHR) | PARD3 | PARD3B | PARD6A | PARD6B | PARD6G | PARD6G-AS1 | PARG | PARGP1 | PARK7 | PARL | PARM1 | PARM1-AS1 | PARN | PARP1 | PARP10 | PARP11 | PARP12 | PARP14 | PARP15 | PARP16 | PARP2 | PARP3 | PARP4 | PARP6 | PARP8 | PARP9 | PARPBP | PARS2 | PART1 | PARTICL | PARVA | PARVB | PARVG | Parvovirus initiator complex | PASD1 | PASK | Patatin-like phospholipase domain-containing protein | PATE1 | PATE2 | PATE3 | PATE4 | PATJ | PATL1 | PATL2 | PATZ1 | PAUPAR | PAWR | PAX1 | PAX2 | PAX3 | PAX4 | PAX5 | PAX6 | PAX6-AS1 | PAX7 | PAX8 | PAX8-AS1 | PAX9 | PAXBP1 | PAXBP1-AS1 | PAXIP1 | PAXIP1-AS2 | PAXIP1-DT | PAXX | PBDC1 | PBK | PBLD | PBOV1 | PBRM1 | PBX1 | PBX2 | PBX3 | PBX3-DT | PBX4 | PBXIP1 | PC | PCA3 | PCAF complex | PCARE | PCAT1 | PCAT14 | PCAT18 | PCAT19 | PCAT2 | PCAT29 | PCAT4 | PCAT5 | PCAT6 | PCAT7 | PCBD1 | PCBD2 | PCBP1 | PCBP1-AS1 | PCBP2 | PCBP2-OT1 | PCBP2P2 | PCBP3 | PCBP3-AS1